Leukemogenesis in heterozygous PU.1 knockout mice

Radiation Research

Volumn 182, Issue 3, 2014, Pages 310-315

  Genik, Paula C ^a   Vyazunova, Irina ^b   Steffen, Leta S ^b   Bacher, Jeffery W ^b,c   Bielefeldt Ohmann, Helle ^d   McKercher, Scott ^e   Ullrich, Robert L ^f   Fallgren, Christina M ^a   Weil, Michael M ^a   Ray, F Andrew ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b PROMEGA CORPORATION   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e BURNHAM INSTITUTE   (United States)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 2; CHROMOSOME DELETION; CODON; CONTROLLED STUDY; GAMMA RADIATION; GENOTYPE; HETEROZYGOSITY LOSS; KNOCKOUT MOUSE; LEUKEMOGENESIS; MALE; MICROSATELLITE INSTABILITY; MONITORING; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; TIME; TREATMENT DURATION;

ANIMALS; CHROMOSOME DELETION; CODON; FMS-LIKE TYROSINE KINASE 3; HETEROZYGOTE; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, RADIATION-INDUCED; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICROSATELLITE INSTABILITY; MUTATION; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS;

EID: 84907366342     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13738.1     Document Type: Article

References (26)

1. Major IR, Mole RH. Myeloid leukaemia in x-ray irradiated CBA mice. Nature 1978; 272:455-6.
2. Mole RH, Papworth DG, Corp MJ. The dose-response for x-ray induction of myeloid-leukemia in male CBA/H mice. Br J Cancer 1983; 47:285-91.
3. Weil MM, Bedford JS, Bielefeldt-Ohmann H, Ray FA, Genik PC, Ehrhart EJ, et al. Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon (56)Fe ions. Radiat Res 2009; 172:213-9.
4. Cook WD, McCaw BJ, Herring C, John DL, Foote SJ, Nutt SL, et al. PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. Blood 2004; 104:3437-44.
5. Suraweera N, Meijne E, Moody J, Carvajal-Carmona LG, Yoshida K, Pollard P, et al. Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia. Oncogene 2005; 24:3678-83.
6. Peng Y, Brown N, Finnon R, Warner CL, Liu X, Genik PC, et al. Radiation leukemogenesis in mice: loss of PU.1 on chromosome 2 in CBA and C57BL/6 mice after irradiation with 1 GeV/nucleon 56Fe ions, X rays or gamma rays. Part I. Experimental observations. Radiat Res 2009; 171:474-83.
7. Duncan BK, Miller JH. Mutagenic deamination of cytosine residues in DNA. Nature 1980; 287:560-1.
8. Dekkers F, Bijwaard H, Bouffler S, Ellender M, Huiskamp R, Kowalczuk C, et al. A two-mutation model of radiation-induced acute myeloid leukemia using historical mouse data. Radiat Environ Biophys 2011; 50:37-45.
9. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. Embo Journal 1996; 15:5647-58.
10. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor Pu.1 in the development of multiple hematopoietic lineages. Science 1994; 265:1573-7.
11. Metcalf D, Dakic A, Mifsud S, Di Rago L, Wu L, Nutt S. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci U S A 2006; 103:1486-91.
12. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nature Genet 2004; 36:624-30.
13. Ban N, Kai M. Implication of replicative stress-related stem cell ageing in radiation-induced murine leukaemia. Br J Cancer 2009; 101:363-71.
14. Clark DJ, Meijne EI, Bouffler SD, Huiskamp R, Skidmore CJ, Cox R, et al. Microsatellite analysis of recurrent chromosome 2 deletions in acute myeloid leukaemia induced by radiation in F1 hybrid mice. Genes Chromosomes Cancer 1996; 16:238-46.
15. Curik N, Burda P, Vargova K, Pospisil V, Belickova M, Vlckova P, et al. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity. Leukemia 2012; 26:1804-11.
16. Finnon R, Brown N, Moody J, Badie C, Olme CH, Huiskamp R, et al. Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia. Leukemia 2012; 26:1445-6.
17. Steffen LS, Bacher JW, Peng Y, Le PN, Ding LH, Genik PC, et al. Molecular characterisation of murine acute myeloid leukaemia induced by 56Fe ion and 137Cs gamma ray irradiation. Mutagenesis 2013; 28:71-9.
18. Hirouchi T, Takabatake T, Yoshida K, Nitta Y, Nakamura M, Tanaka S, et al. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice. Exp Hematol 2008; 36:871-85.
19. Boulton E, Cleary H, Papworth D, Plumb M. Susceptibility to radiation-induced leukaemia/lymphoma is genetically separable from sensitivity to radiation-induced genomic instability. Int J Radiat Biol 2001; 77:21-9.
20. Meijne E, Huiskamp R, Haines J, Moody J, Finnon R, Wilding J, et al. Analysis of loss of heterozygosity in lymphoma and leukaemia arising in F1 hybrid mice locates a common region of chromosome 4 loss. Genes Chromosomes Cancer 2001; 31:373-81.
21. Wimmer K, Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?. Hum Genet 2008; 124:105-22.
22. Wimmer K, Kratz CP. Constitutional mismatch repair-deficiency syndrome. Haematologica 2010; 95:699-701.
23. Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 2002; 100:59-66.
24. Walter MJ, Park JS, Ries RE, Lau SK, McLellan M, Jaeger S, et al. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PMLRARalpha. Proc Natl Acad Sci U S A 2005; 102:12513-8.
25. Harbour JW. Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol 2001; 119:1699-704.
26. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820-3.